reference/27573331

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27573331

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	4254
issn	0732-183X 1527-7755
issueIdentifier	27
pageRange	4247-4254
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	4247
bibliographicCitation	Chi KN, Hotte SJ, Yu EY, Tu D, Eigl BJ, Tannock I, Saad F, North S, Powers J, Gleave ME, Eisenhauer EA. Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer. J Clin Oncol. 2010 Sep 20;28(27):4247–54. doi: 10.1200/jco.2009.26.8771. PMID: 20733135.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dab8c7af7544e564c939c5f8fa2e5df3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_855a0f72b7c0acca369ecec280e0c951 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23f8fac382a2332ec4fcf56a89d5f7b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b3f1cf46fe37ab153b795f1a9a28e3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_226a280f2eea87917cd0633535377654 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3f8bdb7aceae70c7f41be7dc3adc5e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8e7d588c38d1af755f947dd965a5128 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c13a188914b777c4d62b3f0740fafe31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd33d60676f598d1290205ea9ac6bab0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60970449f1c62beea7b56f7f42339831 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d002785f7ceef09a3cefc3cff243bfe9
date	2010-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20733135 https://doi.org/10.1200/jco.2009.26.8771
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
discusses	http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0082230 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0468853 http://id.nlm.nih.gov/mesh/M0489321 http://id.nlm.nih.gov/mesh/M0021363 http://id.nlm.nih.gov/mesh/M0026444 http://id.nlm.nih.gov/mesh/M0017465
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D009919
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D043823Q000008 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D011471Q000601 http://id.nlm.nih.gov/mesh/D051152Q000235 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D014861 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D017430Q000097 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D002170 http://id.nlm.nih.gov/mesh/D013873Q000008 http://id.nlm.nih.gov/mesh/D051152Q000097 http://id.nlm.nih.gov/mesh/D011471Q000097 http://id.nlm.nih.gov/mesh/D011471Q000556 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D013997
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56841793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8382 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.77 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_19e0fa430b5a0437b87cf5bf7a365011 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10698

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660

Total number of triples: 79.